Oxford BioMedica
Elizabeth Ellis is a highly experienced professional in the biotech and pharmaceutical industries, currently serving as Senior Director of Process Development at Oxford Biomedica since February 2019. Prior roles include Director of Process Development at the same company and Head of Downstream Development at Alvotech from August 2016 to December 2018. Elizabeth's earlier experience includes positions as Senior Manager in Quality Control at Sekisui Diagnostics, LLC, and various roles at Abbott, including Analytics Manager and Materials Movement Team Leader. Elizabeth holds a BSc (Hons) in Biological Sciences from the University of Reading and completed A-levels in Biology, Physics, Geography, and Design Technology at Chatham Grammar School for Girls.
This person is not in any teams
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.